Showing results (961-970 of 1,996) with videos related to

Sort By:
Pageof 200
The Lancet. Neurology|July 26, 2024
Safety, tolerability, and pharmacokinetics of antisense oligonucleotide BIIB078 in adults with C9orf72-associated amyotrophic lateral sclerosis: a phase 1, randomised, double blinded, placebo-controlled, multiple ascending dose studyLeonard H van den Berg, Jeffrey D Rothstein, Pamela J Shaw, et al.
The Lancet. Neurology|June 30, 2024
Effects of spaceflight on the brainRachael D Seidler, Xiao Wen Mao, Grant D Tays, et al.
The Lancet. Neurology|August 16, 2024
Safety and efficacy of intra-erythrocyte dexamethasone sodium phosphate in children with ataxia telangiectasia (ATTeST): a multicentre, randomised, double-blind, placebo-controlled phase 3 trialStefan Zielen, Thomas Crawford, Luca Benatti, et al.
The Lancet. Neurology|June 15, 2024
Optimal drainage time after evacuation of chronic subdural haematoma (DRAIN TIME 2): a multicentre, randomised, multiarm and multistage non-inferiority trial in DenmarkMads Hjortdal Grønhøj, Thorbjørn Søren Rønn Jensen, Rares Miscov, et al.
The Lancet. Neurology|June 16, 2024
Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trialMark W Parsons, Vignan Yogendrakumar, Leonid Churilov, et al.
The Lancet. Neurology|May 17, 2024
B cell-targeting chimeric antigen receptor T cells as an emerging therapy in neuroimmunological diseasesAiden Haghikia, Georg Schett, Dimitrios Mougiakakos
The Lancet. Neurology|April 17, 2024
Improving epilepsy diagnosis across the lifespan: approaches and innovationsJacob Pellinen, Emma C Foster, Jo M Wilmshurst, et al.
The Lancet. Neurology|January 24, 2026
Safety and efficacy of adjunct dexamethasone in adults with herpes simplex virus encephalitis in the UK (DexEnceph): a multicentre, observer-blind, randomised, phase 3, controlled trialTom Solomon, Cory Hooper, Ava Easton, et al.
The Lancet. Neurology|January 25, 2026
Epileptic activity in Alzheimer's disease: emerging insights and therapeutic implicationsKeith Vossel, Emily L Johnson, Benjamin Cretin, et al.
The Lancet. Neurology|November 24, 2025
Seizure-related biomarkers of sudden unexpected death in epilepsy (SUDEP) in drug-resistant focal epilepsy (REPO2MSE): a prospective, multicentre case-control studyPhilippe Ryvlin, Margaux Huot, Luc Valton, et al.
Pageof 200